Bladder Cancer
Kidney Cancer
EAU Edu Platform on Prostate Cancer
Home
Articles
Article of the Month
Editorial
Videos
Webcasts
Education
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorial
Videos
Webcasts
Education
Terug
Curriculum: mPCa patients treatment
Curriculum: CVD risk in PCa patients
E-courses
ESOU Online
Webinars
Guidelines
Events
Upcoming event
40th Annual EAU Congress
Home
/
Videos
Back
UROonco24
EAU24
EAU23
ASCO GU23
EMUC2022
ESMO2022
EAU22
ASCO22
ASCO GU22
EMUC21
EAU 21
ASCO GU21
EAU20
ESOU Online
ASCO19
EAU19
GU19
EMUC 2018
EMUC 2014
ESMO 2014
ERUS 2014
Filter
Tags
Abiraterone
,
Active surveillance
,
Adjuvant
,
ADT
,
Advanced prostate cancer
,
Alkaline phosphatase
,
Alternative splicing
,
Androgen
,
Androgen deprivation therapy
,
Androgen pathway blockade
,
Androgen receptor inhibitor
,
Antiandrogens
,
Anticancer agents
,
ARCHES
,
Article of the Month
,
ASCO GU21
,
ASCO GU22
,
ASCO21
,
AUA21
,
BHC80
,
Biochemical recurrence
,
Biomarkers
,
Biopsy
,
Bisphosphonates
,
Bone metastases
,
BRCA1
,
BRCA2
,
Castrate-resistanter
,
Castration-resistant
,
Chemotherapy
,
Clinical trial
,
Clinical trials
,
Cohort study
,
COVID-19
,
cSP
,
Deferred treatment
,
Diagnosis
,
Disease progression
,
Docetaxel
,
EAU21
,
EAU22
,
Emission-computed
,
EMUC21
,
EMUC22
,
End-to-side nerve grafting
,
Enzalutamide
,
Erectile dysfunction
,
Erectile function
,
ESMO21
,
ESMO22
,
ESOU Online
,
ESU Masterclass
,
ESU Masterclasses
,
External beam radiotherapy
,
Focal therapy
,
Frozen section
,
Fusion biopsies
,
Genomic classifier
,
Genomics
,
Guidelines
,
hormone-sensitive
,
HORRAD
,
HRQL
,
Image guided biopsy
,
Imaging
,
Immunohistochemistry
,
Index lesion
,
Indocyanine green
,
Intensity-modulated radiotherapy
,
Local radiotherapy
,
Localised
,
Localized
,
Localized prostate cancer
,
Lymph node excision
,
Lymphadenectomy
,
Mapping
,
Mass spectrometry
,
Masterclass
,
Masterclasses
,
MDV3100
,
Membranous urethra
,
Meta-analysis
,
Metastasis
,
Metastasized
,
Metastatic
,
Mortality reduction
,
mp-MRI
,
MRI
,
Neoplasm staging
,
Nerve sparing
,
Next-generation sequencing
,
Nomogram
,
Noncastrate
,
Orchiectomy
,
Overdiagnosis
,
p53
,
Patient information
,
PCa21
,
Penile rehabilitation
,
PET/CT
,
Positron emission tomography
,
Precision medicine
,
Pretreatment risk stratification
,
Pretreatment tables
,
Primary tumor treatment
,
Prognosis
,
Prognostic model
,
Prostasomes
,
Prostate screening
,
Prostate-specific antigen
,
Prostate-specific membrane antigen
,
Prostatic neoplasms
,
ProtecT trial
,
Proteomics
,
PSA
,
PSA flare
,
PSA kinetics
,
PSA screening
,
PSMA PET/CT
,
PTEN
,
Quality of life
,
Radiation therapy
,
Radical prostatectomy
,
Randomized prospective trial
,
Randomized trial
,
Randomized trials
,
Rapid metastasis
,
Rb
,
RB1
,
Receptors
,
Risk stratification
,
RNA splicing
,
Robotic prostatectomy
,
Robotic surgery
,
Robotic Urology
,
Robotics
,
Salvage therapy
,
Screening
,
Sentinel lymph node
,
Sexual quality of life
,
SREs
,
SRRM4
,
STAMPEDE
,
Stereotactic body radiotherapy
,
Surgical margins
,
Surgical video
,
Surgical videos
,
Systematic biopsy
,
Systematic review
,
Targeted Biopsy
,
TITAN
,
TP53
,
Transcriptome
,
Transperineal template biopsy
,
Tumor suppressor genes
,
Ultrasensitive PSA
,
Urinary incontinence
,
Urological surgery
,
Urowebinar
,
WCRF/AICR CUP
,
Webinar
,
Wnt
,
Zoledronic acid
Show all
PRESTO study
Watch now
ESOU Online: EAU22 highlights in prostate cancer
Watch now
ARNEO trial
Watch now
Limited bone involvement detected by PSMA PET only: From curative to palliative treatment?
Watch now
Updated overall survival outcomes in ENZAMET (ANZUP 1304), an international, cooperative group trial of enzalutamide in metastatic hormone-sensitive prostate cancer
Watch now
Cohort study of patients with oligorecurrent prostate cancer: Oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery
Watch now
Phase 3 MAGNITUDE study
Watch now
PROpel trial
Watch now
Association of RB1 mutational status with overall genomic landscape in neuroendocrine prostate cancer (NEPC)
Watch now
TheraP trial
Watch now
Lecture on the role of neo adjuvant androgen deprivation before radical prostatectomy
Watch now
Case discussion on which is the best combination treatment for de novo mHSPC
Watch now
Previous
Next